ABSTRACT We assessed the prescription patterns of oral antidiabetic drugs in Japanese patients with type 2 diabetes between 2002 and 2020 using data from the Computerized Diabetes Care database. Among 172,960 patients treated with oral antidiabetic drugs, both the sulfonylurea prescription rate and dose decreased from 2002 to 2020. Prescriptions of biguanides, dipeptidyl peptidase‐4 inhibitors and sodium–glucose cotransporter 2 inhibitors increased; their dose and dose frequency remained relatively stable. Trends in oral antidiabetic drug prescriptions changed over time, reflecting guideline recommendations and existing evidence
Aims/Introduction: We compared clinical characteristics in patients with type 2 diabetes for whom di...
BackgroundThe number of patients with diabetes is increasing particularly in Asia-Pacific region. Ma...
Abstract In Japan, the choice of anti-diabetic medication is officially recommended according to the...
Aims/Introduction:Type 2 diabetes mellitus is caused by a relative imbalance between insulin secreti...
Introduction Prescription patterns of antidiabetic drugs in the period from 2012 to 2018 were invest...
Abstract Background We examined the long-term changes in the management of diabetes at a single inst...
[[abstract]]The purpose of this study was to evaluate the prescription trend and pattern of oral ant...
Little is known about the relationships between patient factors and the antihyperglycemic agents tha...
The impact of the introduction of newer anti-diabetic agents on the treatment pattern in the booming...
OBJECTIVE — To describe the use of oral antidiabetic drugs for management of type 2 diabetes in the ...
The ADA (American Diabetic Association) and NICE (National Institute for Clinical Evidence) in the U...
[[abstract]]BACKGROUND/PURPOSE: Several new antidiabetic drugs have been introduced in Taiwan. Howev...
OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...
Background Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabet...
BackgroundThe number of patients with diabetes is increasing particularly in Asia-Pacific region. Ma...
Aims/Introduction: We compared clinical characteristics in patients with type 2 diabetes for whom di...
BackgroundThe number of patients with diabetes is increasing particularly in Asia-Pacific region. Ma...
Abstract In Japan, the choice of anti-diabetic medication is officially recommended according to the...
Aims/Introduction:Type 2 diabetes mellitus is caused by a relative imbalance between insulin secreti...
Introduction Prescription patterns of antidiabetic drugs in the period from 2012 to 2018 were invest...
Abstract Background We examined the long-term changes in the management of diabetes at a single inst...
[[abstract]]The purpose of this study was to evaluate the prescription trend and pattern of oral ant...
Little is known about the relationships between patient factors and the antihyperglycemic agents tha...
The impact of the introduction of newer anti-diabetic agents on the treatment pattern in the booming...
OBJECTIVE — To describe the use of oral antidiabetic drugs for management of type 2 diabetes in the ...
The ADA (American Diabetic Association) and NICE (National Institute for Clinical Evidence) in the U...
[[abstract]]BACKGROUND/PURPOSE: Several new antidiabetic drugs have been introduced in Taiwan. Howev...
OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...
Background Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabet...
BackgroundThe number of patients with diabetes is increasing particularly in Asia-Pacific region. Ma...
Aims/Introduction: We compared clinical characteristics in patients with type 2 diabetes for whom di...
BackgroundThe number of patients with diabetes is increasing particularly in Asia-Pacific region. Ma...
Abstract In Japan, the choice of anti-diabetic medication is officially recommended according to the...